Zhixiang Guo

662 total citations
28 papers, 506 citations indexed

About

Zhixiang Guo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zhixiang Guo has authored 28 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Zhixiang Guo's work include T-cell and Retrovirus Studies (3 papers), Cancer-related molecular mechanisms research (3 papers) and Animal Disease Management and Epidemiology (3 papers). Zhixiang Guo is often cited by papers focused on T-cell and Retrovirus Studies (3 papers), Cancer-related molecular mechanisms research (3 papers) and Animal Disease Management and Epidemiology (3 papers). Zhixiang Guo collaborates with scholars based in China, Bulgaria and United States. Zhixiang Guo's co-authors include Shenglin Ge, Chengxin Zhang, Wenhui Gong, Haiyuan Liu, Zhuang Liu, Xiao-Yong Wei, Fei Sun, Xinming Wu, Qin Wang and Peng Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Zhixiang Guo

25 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixiang Guo China 14 233 131 116 48 46 28 506
Yinguang Li China 14 209 0.9× 145 1.1× 124 1.1× 35 0.7× 24 0.5× 31 575
Chuanwu Wang China 15 145 0.6× 22 0.2× 414 3.6× 88 1.8× 32 0.7× 33 764
Yuncong Zhang China 15 281 1.2× 172 1.3× 61 0.5× 87 1.8× 43 0.9× 26 610
Yasumasa Yoshizawa Japan 6 130 0.6× 56 0.4× 22 0.2× 58 1.2× 12 0.3× 16 391
Xianxin Li China 16 516 2.2× 364 2.8× 30 0.3× 68 1.4× 18 0.4× 53 862
Yuji Maruo Japan 9 99 0.4× 29 0.2× 16 0.1× 90 1.9× 31 0.7× 34 317
Pengfei Fang China 9 304 1.3× 108 0.8× 116 1.0× 73 1.5× 27 0.6× 21 461
A Rich United States 6 611 2.6× 60 0.5× 523 4.5× 93 1.9× 71 1.5× 8 1.1k
Meiting Chen China 16 462 2.0× 248 1.9× 76 0.7× 140 2.9× 46 1.0× 70 857
Xinyao Wu China 12 227 1.0× 27 0.2× 197 1.7× 57 1.2× 35 0.8× 51 568

Countries citing papers authored by Zhixiang Guo

Since Specialization
Citations

This map shows the geographic impact of Zhixiang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixiang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixiang Guo more than expected).

Fields of papers citing papers by Zhixiang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixiang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixiang Guo. The network helps show where Zhixiang Guo may publish in the future.

Co-authorship network of co-authors of Zhixiang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixiang Guo. A scholar is included among the top collaborators of Zhixiang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixiang Guo. Zhixiang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Zhixiang, et al.. (2025). Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α. Therapeutic Advances in Gastroenterology. 18. 1128501013–1128501013. 1 indexed citations
2.
Sun, Yanli, Fengying Zhang, Lixin Zhou, et al.. (2025). Discovery of Potent, Allosteric GSTO1 Covalent Inhibitors with a New Binding Mode. Journal of Medicinal Chemistry. 68(22). 24075–24093.
3.
Yu, Jiaojiao, Huihui� Guo, Yuanyuan Huang, et al.. (2025). The anti-STEAP1/PSMA ADC, DXC008: Assessment of anti-tumor efficacy, pharmacokinetic, and toxicity properties.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
4.
Wu, Xinming, et al.. (2025). Intelligent Traffic Monitoring with Distributed Acoustic Sensing. Seismological Research Letters. 96(4). 2477–2488. 4 indexed citations
5.
Wei, Yiwen, et al.. (2024). Advances in phage–host interaction prediction: in silico method enhances the development of phage therapies. Briefings in Bioinformatics. 25(3). 16 indexed citations
6.
Xu, Peng, et al.. (2024). Monotropein alleviates acute pulmonary embolism in rats by inhibiting the NF-κB pathway. Immunopharmacology and Immunotoxicology. 46(6). 893–901.
8.
Li, Hao, Yi Xiao, Zhixiang Guo, et al.. (2024). Pentraxin-3 modulates hepatocyte ferroptosis and the innate immune response in LPS-induced liver injury. Molecular Biomedicine. 5(1). 68–68. 3 indexed citations
10.
Zhang, Chengxin, Wenhui Gong, Zhixiang Guo, et al.. (2020). LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype. Cell Death and Disease. 11(6). 435–435. 72 indexed citations
11.
Wang, Qun, Zhixiang Guo, Jinbin Li, et al.. (2020). Population dynamics and diversity of butterflies in Ailaoshan and Wuliangshan national nature reserves, Yunnan Province. Biodiversity Science. 28(8). 921–930. 1 indexed citations
12.
Guo, Zhixiang, et al.. (2020). Effects of respiratory rate on venous-to-arterial CO2 tension difference in septic shock patients undergoing volume mechanical ventilation. European journal of medical research. 25(1). 6–6. 3 indexed citations
13.
Sun, Fei, et al.. (2019). LncRNA NRON alleviates atrial fibrosis through suppression of M1 macrophages activated by atrial myocytes. Bioscience Reports. 39(11). 38 indexed citations
14.
Xu, Peng, et al.. (2019). LncRNA NRON alleviates atrial fibrosis via promoting NFATc3 phosphorylation. Molecular and Cellular Biochemistry. 457(1-2). 169–177. 21 indexed citations
15.
Wang, Jie, Di Song, Guangjian Lu, et al.. (2017). HLA-DMB restricts human T-cell leukemia virus type-1 (HTLV-1) protein expression via regulation of ATG7 acetylation. Scientific Reports. 7(1). 14416–14416. 5 indexed citations
16.
Wang, Jie, Di Song, Lu Liu, et al.. (2017). Ku70 Senses HTLV-1 DNA and Modulates HTLV-1 Replication. The Journal of Immunology. 199(7). 2475–2482. 35 indexed citations
17.
Guo, Zhixiang, Peng Xu, Chengxin Zhang, et al.. (2017). Ubiquitin specific peptidase 4 stabilizes interferon regulatory factor protein and promotes its function to facilitate interleukin-4 expression in T helper type 2 cells. International Journal of Molecular Medicine. 40(4). 979–986. 14 indexed citations
18.
Guo, Zhixiang, et al.. (2017). Peratrial Device Closure of Atrial Septal Defect Under Transesophageal Echocardiographic Guidance without Fluoroscopy Compared to Conventional On-Pump Surgical Closure. Brazilian Journal of Cardiovascular Surgery. 32(1). 38–42. 1 indexed citations
19.
Yang, Jing, Peng Xu, Lei Han, et al.. (2015). Cutting Edge: Ubiquitin-Specific Protease 4 Promotes Th17 Cell Function under Inflammation by Deubiquitinating and Stabilizing RORγt. The Journal of Immunology. 194(9). 4094–4097. 64 indexed citations
20.
Zhang, Chengxin, Wenhui Gong, Haiyuan Liu, Zhixiang Guo, & Shenglin Ge. (2014). Inhibition of matrix metalloproteinase-9 with low-dose doxycycline reduces acute lung injury induced by cardiopulmonary bypass.. PubMed. 7(12). 4975–82. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026